Estabrook Capital Management Elanco Animal Health Inc Transaction History

Estabrook Capital Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$8.79 - $14.58 $33,402 - $55,404	-3,800 Reduced 29.69%	9,000 $84.6 Million
Q4 2022 Feb 13, 2023	SELL	$11.49 - $13.65 $86,175 - $102,375	-7,500 Reduced 36.95%	12,800 $156 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $31,025 - $81,050	-2,500 Reduced 10.96%	20,300 $252 Million
Q1 2022 May 13, 2022	SELL	$24.65 - $29.0 $18,487 - $21,750	-750 Reduced 3.18%	22,800 $594,000
Q2 2021 Aug 13, 2021	BUY	$28.76 - $35.98 $35,950 - $44,974	1,250 Added 5.61%	23,550 $816,000
Q3 2020 Nov 13, 2020	SELL	$21.1 - $29.13 $105,478 - $145,620	-4,999 Reduced 18.31%	22,300 $622,000
Q2 2020 Aug 13, 2020	SELL	$18.94 - $24.93 $112,522 - $148,109	-5,941 Reduced 17.87%	27,299 $585,000
Q1 2020 May 14, 2020	BUY	$16.68 - $32.25 $196,607 - $380,130	11,787 Added 54.94%	33,240 $744,000
Q4 2019 Feb 13, 2020	BUY	$25.29 - $29.45 $446,393 - $519,821	17,651 Added 464.26%	21,453 $631,000
Q3 2019 Nov 13, 2019	BUY	$25.62 - $34.96 $97,407 - $132,917	3,802 New	3,802 $101,000

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

Stay updated on Estabrook Capital Management with notifications on news.